Belong.Life’s Advanced AI Technology Selected to Power New Menopause Support Solution

‘Ask Elina’ Harnesses Belong’s Data and Expertise in Conversational AI to Help Women Navigate Menopause, Manage Symptoms and Explore Options

NEW YORK, April 7, 2025 /PRNewswire/ — Belong.Life, a leader in AI-driven patient education and engagement solutions, today announced that its AI Health Mentor SaaS solution has been selected to power Ask Elina, a new app designed to help women effectively navigate perimenopause and menopause.

The menopause journey can be confusing, frustrating, and isolating. Ask Elina is designed to help women navigate these challenges with confidence. Powered by Belong’s AI technology, Elina is a highly trained health coach who helps users navigate the overwhelming influx of information about menopause. Elina gets to know users personally and provides evidence-based insights and guidance tailored to their needs while helping them manage symptoms and understand their options.

“We chose Belong.Life’s AI mentor technology for its proven success in delivering an effective health support platform that excels in user experience and accuracy,” said Nathalie Belanger, Co-Founder of Ask Elina. “Women deserve a trusted, personalized resource to help them navigate menopause, and with Belong’s SaaS solution, we’re making that a reality. Perimenopause lasts seven years on average and more than 25 million women around the world enter menopause annually. Empowering women with on-demand, easy-to-understand, evidence-based information tailored to their unique journey is essential for supporting their long-term well-being.”

Ask Elina was founded by seasoned executives Nathalie Belanger and Elizabeth Wasserman. Belanger, a former Vice President at both Reitmans retail company and Aeroplan, brings extensive expertise in omnichannel strategies and customer engagement, while Wasserman, the founder of dating platform Mate1.com, successfully built and scaled a global online community of over 50 million users. Their expertise, combined with Belong’s AI technology, positions them to bring a best-in-class digital health solution to market.

“Perimenopause can be an incredibly lonely and frightening time for many women,” said Elizabeth Wasserman, Co-Founder of Ask Elina. “Healthcare providers often dismiss these experiences, leaving women to navigate this transition alone. We’re creating a companion that offers both knowledge and compassion when women need it most.”

Belong’s proprietary AI technology has already demonstrated success in patient communities across oncology and multiple sclerosis, with platforms such as Dave the Cancer Mentor and BelongMS. This collaboration marks Belong’s expansion into women’s health, reinforcing its commitment to leveraging AI to address critical healthcare challenges.

“Women navigating menopause are often underserved, and Ask Elina tackles this head-on with an accessible and easy to use AI-powered companion,” said Eliran Malki, Co-Founder and CEO of Belong.Life. “Our AI SaaS platform will support women during this critical stage of their lives. This collaboration highlights how AI can bridge gaps in healthcare by offering scalable, always-available support for women managing complex health transitions.”

“The opportunity to impact millions of women navigating menopause is immense, and we are proud to contribute to a solution that delivers accurate, compassionate, and individualized care at scale,” said Irad Deutsch, Co-Founder and CTO of Belong.Life. “We are committed to maintaining the highest standards of safety and privacy, ensuring that all users can trust our platform to securely access the tools and insights they need during transformative stages of their lives.”

Ask Elina is expected to launch in May 2025. Women interested in early access can join the waitlist at www.askelina.com.

About Belong.Life

Belong.Life is a leader in digital health solutions transforming the patient experience and deliver value for patients, healthcare providers, pharmaceutical companies, and payers. Belong’s key solutions include the world’s largest social and professional networks for people living with cancer (Belong – Beating Cancer Together) and multiple sclerosis (BelongMS). Its AI-driven patient engagement platforms proactively support and empower patients throughout their healthcare journey. These include Dave – AI Cancer Mentor, validated by top oncologists and research presented at ASCO and ESMO, along with Sophie – AI MS MentorTara – AI Clinical Trials Matching Assistant and Fred – AI Weight and Health Mentor. By providing patient education, 24/7 support, and access to relevant clinical trials, Belong is helping to improve healthcare outcomes worldwide. Belong’s solutions are multilingual, HIPAA, GDPR and ISO compliant.

For more information visit https://belong.life/.
Follow Belong on FacebookX, and LinkedIn.

About ‘Ask Elina’

Ask Elina is a pioneering digital health platform dedicated to supporting women through perimenopause and menopause with personalized, evidence-based guidance and a private community. Founded by tech executives Nathalie Belanger and Elizabeth Wasserman, Ask Elina combines advanced AI technology with deep understanding of women’s health needs to provide accessible, compassionate support during this significant life transition. Through its intuitive interface and sophisticated personalization capabilities, Ask Elina aims to transform how women experience and manage menopause, empowering them with knowledge and confidence to make informed health decisions.

For more information and to join the waitlist, visit www.askelina.com.

Media Contact:
Ellie Hanson
FINN Partners
ellie.hanson@finnpartners.com 
929-588-2008

Photo: https://healthtechnologynet.com/wp-content/uploads/2025/04/BelongLife_Ask_Elina.jpg

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/belonglifes-advanced-ai-technology-selected-to-power-new-menopause-support-solution-302421825.html

SOURCE Belong.Life

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

6 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

6 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago